Ifezuntirgene inilparvovec is the first investigational therapy for Huntington’s disease to have received Breakthrough Therapy and Regenerative Medicine Advanced Therapy (RMAT) designations from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results